株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

更年期顔面紅潮:パイプライン製品の分析

Menopausal Hot Flashes - Pipeline Review, H2 2015

発行 Global Markets Direct 商品コード 192701
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
更年期顔面紅潮:パイプライン製品の分析 Menopausal Hot Flashes - Pipeline Review, H2 2015
出版日: 2015年11月25日 ページ情報: 英文 58 Pages
概要

顔面紅潮とは、体温が突然上昇したように感じる症状で、特に更年期には一般的に見られる症状です。特に、顔面・頚部・胸部で強く現れます。主な症状として、心拍数の急増や、上半身を中心とした発汗、紅潮が収まった際の悪寒などが上げられます。疾病素質には喫煙や運動不足、肥満などが含まれています。主な治療薬には、ホルモン療法や抗うつ剤などがあります。

当レポートでは、世界各国での更年期顔面紅潮治療用のパイプライン製品の開発状況について分析し、製品開発・上市の最新動向や、治験の各段階にある製品の一覧、主要企業のプロファイル、主な薬剤の概要、最新の業界動向などの情報をお届けします。

目次

イントロダクション

  • 分析範囲

更年期顔面紅潮の概要

治療薬の開発

  • 更年期顔面紅潮向けパイプライン製品:概要
  • 更年期顔面紅潮向けパイプライン製品:比較分析

各企業で開発中の更年期顔面紅潮治療薬

パイプライン製品の概略

  • 治験段階の製品
  • 初期段階の製品
  • 不明確な段階にある製品

更年期顔面紅潮治療薬:開発中の製品の一覧(企業別)

更年期顔面紅潮治療薬の開発に従事している企業

  • エーザイ
  • Concert Pharmaceuticals, Inc.
  • PharmaNova Inc.
  • Intra-Cellular Therapies, Inc.
  • Pherin Pharmaceuticals, Inc.

更年期顔面紅潮:治療薬の評価

  • 単剤治療薬の場合
  • 標的別
  • 作用機序別
  • 投与方法別
  • 分子の種類別

薬剤のプロファイル

  • ガバペンチンER(持続放出)
    • 製品概要
    • 機能メカニズム
    • 研究開発(R&D)の進展状況
  • RAD-1901
  • PH-80-HF
  • CTP-347
  • 更年期顔面紅潮向け小分子
  • 臭化メチルホマトロピン

更年期顔面紅潮治療薬:パイプライン製品の最新動向

更年期顔面紅潮治療薬:開発が休止状態の製品

更年期顔面紅潮治療薬:開発が中止された製品

更年期顔面紅潮関連製品の開発のマイルストーン

  • 注目すべき最新動向・プレスリリース(全10件)

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC7386IDB

Summary

Global Markets Direct's, 'Menopausal Hot Flashes - Pipeline Review, H2 2015', provides an overview of the Menopausal Hot Flashes's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Menopausal Hot Flashes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Menopausal Hot Flashes
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Menopausal Hot Flashes and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Menopausal Hot Flashes pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Menopausal Hot Flashes Overview
  • Therapeutics Development
    • Pipeline Products for Menopausal Hot Flashes - Overview
    • Pipeline Products for Menopausal Hot Flashes - Comparative Analysis
  • Menopausal Hot Flashes - Therapeutics under Development by Companies
  • Menopausal Hot Flashes - Pipeline Products Glance
    • Late Stage Products
    • Clinical Stage Products
    • Early Stage Products
    • Unknown Stage Products
  • Menopausal Hot Flashes - Products under Development by Companies
  • Menopausal Hot Flashes - Companies Involved in Therapeutics Development
    • Amgen Inc.
    • EndoCeutics, Inc.
    • Pantarhei Bioscience BV
    • Pherin Pharmaceuticals, Inc.
    • Pivot Pharmaceuticals Inc
    • Radius Health, Inc.
  • Menopausal Hot Flashes - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Combination Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • (prasterone + acolbifene hydrochloride) - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AMG-334 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • estetrol - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-101 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HBN-2 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • homatropine methylbromide - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MNGX-100 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • P-002 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Q-122 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RAD-1901 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Salubrin-HF - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Menopausal Hot Flashes - Recent Pipeline Updates
  • Menopausal Hot Flashes - Dormant Projects
  • Menopausal Hot Flashes - Discontinued Products
  • Menopausal Hot Flashes - Product Development Milestones
    • Featured News & Press Releases
      • Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms
      • Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes
      • Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing
      • Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes
      • Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants
      • Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women
      • Jun 19, 2010: Radius Presents Positive Phase IIa Study Results Of RAD1901 In Reducing Menopausal Hot Flashes
      • Jun 08, 2008: Radius Presents Preclinical Study Of RAD1901 At The Endocrine Society 2007 Annual Meeting
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Menopausal Hot Flashes, H2 2015
  • Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Comparative Analysis by Late Stage Development, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Development, H2 2015
  • Comparative Analysis by Unknown Stage Development, H2 2015
  • Products under Development by Companies, H2 2015
  • Menopausal Hot Flashes - Pipeline by Amgen Inc., H2 2015
  • Menopausal Hot Flashes - Pipeline by EndoCeutics, Inc., H2 2015
  • Menopausal Hot Flashes - Pipeline by Pantarhei Bioscience BV, H2 2015
  • Menopausal Hot Flashes - Pipeline by Pherin Pharmaceuticals, Inc., H2 2015
  • Menopausal Hot Flashes - Pipeline by Pivot Pharmaceuticals Inc, H2 2015
  • Menopausal Hot Flashes - Pipeline by Radius Health, Inc., H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Assessment by Combination Products, H2 2015
  • Number of Products by Stage and Target, H2 2015
  • Number of Products by Stage and Mechanism of Action, H2 2015
  • Number of Products by Stage and Route of Administration, H2 2015
  • Number of Products by Stage and Molecule Type, H2 2015
  • Menopausal Hot Flashes Therapeutics - Recent Pipeline Updates, H2 2015
  • Menopausal Hot Flashes - Dormant Projects, H2 2015
  • Menopausal Hot Flashes - Dormant Projects (Contd..1), H2 2015
  • Menopausal Hot Flashes - Discontinued Products, H2 2015

List of Figures

  • Number of Products under Development for Menopausal Hot Flashes, H2 2015
  • Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Number of Products by Targets, H2 2015
  • Number of Products by Stage and Targets, H2 2015
  • Number of Products by Mechanism of Actions, H2 2015
  • Number of Products by Stage and Mechanism of Actions, H2 2015
  • Number of Products by Routes of Administration, H2 2015
  • Number of Products by Stage and Routes of Administration, H2 2015
  • Number of Products by Molecule Types, H2 2015
  • Number of Products by Stage and Molecule Types, H2 2015
Back to Top